My watch list
my.bionity.com  
Login  

Seegene, Inc. is pioneering the field of multi-pathogen testing. Seegene applies its novel and proprietary Seeplex® system utilizing "DPO (Dual Priming Oligo)" and “ACP (Annealing Control Primer)” to create multi-pathogen tests delivering maximum specificity, reproducibility and sensitivity. With over 260 citations and several patents and patents pending, Seegene has been offering advanced molecular diagnostics services to over 1,000 major global institutes in more than 25 countries. Seegene’s mission is to integrate Seeplex® with disease diagnostics to provide a new guideline for effectively treating patients. Seegene was founded in 2000 and is based in Rockville, MD and Seoul, Korea.

More about Seegene
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE